98. Eosinophilic gastrointestinal disease Clinical trials / Disease details

Clinical trials : 171 / Drugs : 184 - (DrugBank : 47) / Drug target genes : 42 - Drug target pathways : 141

4 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00895817 (ClinicalTrials.gov)	April 2008	6/5/2009	Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis	Comparison of Aerosolized Swallowed Fluticasone to Esomeprazole for the Treatment of Eosinophilic Esophagitis	Eosinophilic Esophagitis	Drug: Swallowed fluticasone;Drug: Esomeprazole	Walter Reed Army Medical Center	NULL	Completed	18 Years	N/A	All	42	N/A	United States
2	NCT00275561 (ClinicalTrials.gov)	November 2005	10/1/2006	Topical Steroid Treatment for Eosinophilic Esophagitis	A Randomized Placebo-controlled Trial of Swallowed Fluticasone in Treatment of Eosinophilic Esophagitis	Eosinophilic Esophagitis	Drug: Fluticasone;Drug: Placebo	Mayo Clinic	NULL	Completed	18 Years	60 Years	All	42	Phase 2	United States
3	NCT00123656 (ClinicalTrials.gov)	August 2004	21/7/2005	Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis	Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis	Esophagitis	Drug: esomeprazole;Drug: fluticasone	University of Utah	American Society for Gastrointestinal Endoscopy	Completed	18 Years	80 Years	Both	30	Phase 2	United States
4	NCT00266578 (ClinicalTrials.gov)	October 2002	15/12/2005	A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders	Effect of Swallowed Fluticasone Propionate on Eosinophilic Esophagitis; A Prospective, Randomized, Placebo-Controlled Trial	Eosinophilic Esophagitis	Drug: Fluticasone Propionate	Marc Rothenberg	NULL	Completed	3 Years	30 Years	Both	30	Phase 3	United States